ArticleBMC infectious diseases2025
Pronounced effects of the sepsis-obesity paradox in elderly and male individuals without septic shock and the role of immune-inflammatory status: an analysis of MIMIC-IV data.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Metabolic Syndrome Is Associated With Increased Risk ofOpen forum infectious diseases · 2026Article
- Association of Body Mass Index with 28-Day Mortality in Adult Intensive Care Patients with Sepsis: A Retrospective Observational Study.Sisli Etfal Hastanesi tip bulteni · 2026Article
- Development and validation of a nomogram for early nutritional risk stratification in elderly patients with pulmonary sepsis: a retrospective cohort study.Frontiers in nutrition · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundObesity has been shown to reduce short-term mortality in sepsis patients, but the main subgroups and its role in immune-related inflammatory status require further research. The aim of this study was to identify the primary beneficiaries of the sepsis-obesity paradox and to investigate the involvement of immune-inflammatory status.
methodsIn this study, we analyzed data from 6602 sepsis patients from the MIMIC-IV database. Body mass index (BMI) was divided into quartiles, and mortality rates were assessed for each interval. Logistic trend tests and subgroup and restricted cubic spline (RCS) analyses were performed. Blood biochemical indicators were compared across different BMI ranges and between survivors and non-survivors. The receiver operating characteristic (ROC) curve for 28-day mortality was also evaluated.
resultsThe 28-day mortality of sepsis patients followed a U-shaped pattern with increasing BMI. Trend analysis confirmed that BMI was a significant risk factor for 28-day mortality (p < 0.05). Subgroup analysis revealed an interactive effect of BMI on 28-day mortality in elderly (≥ 65 years old), male, and non-septic shock individuals (p < 0.05). A higher BMI was associated with an increased lymphocyte proportion and decreased neutrophil proportion, neutrophil-to-lymphocyte ratio (NLR), and systemic immune-inflammation index (SII) (p < 0.05). Compared with survivors, non-survivors had lower lymphocyte proportions and higher neutrophil proportions, NLRs, and SIIs. ROC analysis revealed that the lymphocyte and neutrophil proportions, NLR, and SII had predictive value for 28-day mortality. Subgroup and RCS analyses revealed that increased BMI was associated with reduced 28-day mortality in sepsis patients, mainly in elderly, male, and septic shock individuals, with protective BMIs ranging from 27.8 ~ 41.7 kg/cm
conclusionsThe sepsis-obesity paradox significantly affects elderly (≥ 65 years old), male, and non-septic shock individuals, displaying a U-shaped pattern for 28-day mortality. BMI may mediate this phenomenon by influencing the body's immune-inflammatory status.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.